Literature DB >> 18987646

The expanding genetic overlap between multiple sclerosis and type I diabetes.

.   

Abstract

Familial clustering of autoimmune disease is well recognized and raises the possibility that some susceptibility genes may predispose to autoimmunity in general. In light of this observation, it might be expected that some of the variants of established relevance in one autoimmune disease may also be relevant in other related conditions. On the basis of this hypothesis, we tested seven single nucleotide polymorphisms (SNPs) that are known to be associated with type I diabetes in a large multiple sclerosis data set consisting of 2369 trio families, 5737 cases and 10,296 unrelated controls. Two of these seven SNPs showed evidence of association with multiple sclerosis; that is rs12708716 from the CLEC16A gene (P=1.6 x 10(-16)) and rs763361 from the CD226 gene (P=5.4 x 10(-8)). These findings thereby identify two additional multiple sclerosis susceptibility genes and lend support to the notion of autoimmune susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987646      PMCID: PMC2718424          DOI: 10.1038/gene.2008.83

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  26 in total

1.  Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey.

Authors:  S A Broadley; J Deans; S J Sawcer; D Clayton; D A Compston
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

2.  CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions.

Authors:  Valerie Dardalhon; Anna S Schubart; Jayagopala Reddy; Jennifer Hartt Meyers; Laurent Monney; Catherine A Sabatos; Rakesh Ahuja; Khuong Nguyen; Gordon J Freeman; Edward A Greenfield; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

3.  Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency.

Authors:  Beate Skinningsrud; Eystein S Husebye; Simon H Pearce; David O McDonald; Kristin Brandal; Anette B Wolff; Kristian Løvås; Thore Egeland; Dag E Undlien
Journal:  J Clin Endocrinol Metab       Date:  2008-07-01       Impact factor: 5.958

Review 4.  Cellular ligands of activating NK receptors.

Authors:  Cristina Bottino; Roberta Castriconi; Lorenzo Moretta; Alessandro Moretta
Journal:  Trends Immunol       Date:  2005-04       Impact factor: 16.687

5.  MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.

Authors:  Maria Swanberg; Olle Lidman; Leonid Padyukov; Per Eriksson; Eva Akesson; Maja Jagodic; Anna Lobell; Mohsen Khademi; Ola Börjesson; Cecilia M Lindgren; Pia Lundman; Anthony J Brookes; Juha Kere; Holger Luthman; Lars Alfredsson; Jan Hillert; Lars Klareskog; Anders Hamsten; Fredrik Piehl; Tomas Olsson
Journal:  Nat Genet       Date:  2005-04-10       Impact factor: 38.330

6.  Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA).

Authors:  J C Patarroyo; O Stuve; J F Piskurich; S L Hauser; J R Oksenberg; S S Zamvil
Journal:  Genes Immun       Date:  2002-02       Impact factor: 2.676

7.  Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.

Authors:  M J Hohol; E J Orav; H L Weiner
Journal:  Mult Scler       Date:  1999-10       Impact factor: 6.312

Review 8.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

9.  DNAM-1 and PVR regulate monocyte migration through endothelial junctions.

Authors:  Nicolas Reymond; Anne-Marie Imbert; Elisabeth Devilard; Stéphanie Fabre; Christian Chabannon; Luc Xerri; Catherine Farnarier; Claudia Cantoni; Cristina Bottino; Alessandro Moretta; Patrice Dubreuil; Marc Lopez
Journal:  J Exp Med       Date:  2004-05-10       Impact factor: 14.307

10.  The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone.

Authors:  Maria Giovanna Marrosu; Costantino Motzo; Raffaele Murru; Rosanna Lampis; Gianna Costa; Patrizia Zavattari; Daniela Contu; Elisabetta Fadda; Eleonora Cocco; Francesco Cucca
Journal:  Hum Mol Genet       Date:  2004-10-07       Impact factor: 6.150

View more
  61 in total

Review 1.  Multiple sclerosis.

Authors:  Alyssa Nylander; David A Hafler
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

2.  Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency.

Authors:  Ricardo C Ferreira; Qiang Pan-Hammarström; Robert R Graham; Vesela Gateva; Gumersindo Fontán; Annette T Lee; Ward Ortmann; Elena Urcelay; Miguel Fernández-Arquero; Concepción Núñez; Gudmundur Jorgensen; Björn R Ludviksson; Sinikka Koskinen; Katri Haimila; Hilary F Clark; Lars Klareskog; Peter K Gregersen; Timothy W Behrens; Lennart Hammarström
Journal:  Nat Genet       Date:  2010-08-08       Impact factor: 38.330

3.  Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come.

Authors:  William S Bush; Stephen J Sawcer; Philip L de Jager; Jorge R Oksenberg; Jacob L McCauley; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Am J Hum Genet       Date:  2010-04-01       Impact factor: 11.025

Review 4.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

5.  Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases.

Authors:  Amit K Maiti; Xana Kim-Howard; Parvathi Viswanathan; Laura Guillén; Xiaoxia Qian; Adriana Rojas-Villarraga; Celi Sun; Carlos Cañas; Gabriel J Tobón; Koichi Matsuda; Nan Shen; Alejandra C Cherñavsky; Juan-Manuel Anaya; Swapan K Nath
Journal:  Rheumatology (Oxford)       Date:  2010-03-24       Impact factor: 7.580

6.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.

Authors: 
Journal:  Nat Genet       Date:  2009-06-14       Impact factor: 38.330

Review 7.  Genetics and pathogenesis of multiple sclerosis.

Authors:  R L Zuvich; J L McCauley; M A Pericak-Vance; J L Haines
Journal:  Semin Immunol       Date:  2009-09-22       Impact factor: 11.130

8.  Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.

Authors:  Eveliina Jakkula; Virpi Leppä; Anna-Maija Sulonen; Teppo Varilo; Suvi Kallio; Anu Kemppinen; Shaun Purcell; Keijo Koivisto; Pentti Tienari; Marja-Liisa Sumelahti; Irina Elovaara; Tuula Pirttilä; Mauri Reunanen; Arpo Aromaa; Annette Bang Oturai; Helle Bach Søndergaard; Hanne F Harbo; Inger-Lise Mero; Stacey B Gabriel; Daniel B Mirel; Stephen L Hauser; Ludwig Kappos; Chris Polman; Philip L De Jager; David A Hafler; Mark J Daly; Aarno Palotie; Janna Saarela; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2010-02-12       Impact factor: 11.025

9.  Vstm3 is a member of the CD28 family and an important modulator of T-cell function.

Authors:  Steven D Levin; David W Taft; Cameron S Brandt; Christoph Bucher; Edward D Howard; Eric M Chadwick; Janet Johnston; Angela Hammond; Kristen Bontadelli; Daniel Ardourel; LuAnn Hebb; Anitra Wolf; Thomas R Bukowski; Mark W Rixon; Joseph L Kuijper; Craig D Ostrander; James W West; Janine Bilsborough; Brian Fox; Zeren Gao; Wenfeng Xu; Fred Ramsdell; Bruce R Blazar; Katherine E Lewis
Journal:  Eur J Immunol       Date:  2011-03-18       Impact factor: 5.532

Review 10.  Rheumatoid arthritis genetics: 2009 update.

Authors:  Robert M Plenge
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.